Chapter 23: International Standard reagents for harmonization of HPV serology and DNA assays--an update.

[1]  J. Dillner,et al.  Results of the first WHO international collaborative study on the standardization of the detection of antibodies to human papillomaviruses , 2006, International journal of cancer.

[2]  C. Wheeler,et al.  Results of the First World Health Organization International Collaborative Study of Detection of Human Papillomavirus DNA , 2006, Journal of Clinical Microbiology.

[3]  Peter J. F. Snijders,et al.  Bead-Based Multiplex Genotyping of Human Papillomaviruses , 2006, Journal of Clinical Microbiology.

[4]  P. Ahlquist,et al.  Production of infectious human papillomavirus independently of viral replication and epithelial cell differentiation. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[5]  R. DeSalle,et al.  The carcinogenicity of human papillomavirus types reflects viral evolution. , 2005, Virology.

[6]  Cosette M Wheeler,et al.  Prophylactic quadrivalent human papillomavirus (types 6, 11, 16, and 18) L1 virus-like particle vaccine in young women: a randomised double-blind placebo-controlled multicentre phase II efficacy trial. , 2005, The Lancet. Oncology.

[7]  C. Wheeler,et al.  Efficacy of a bivalent L1 virus-like particle vaccine in prevention of infection with human papillomavirus types 16 and 18 in young women: A randomized, controlled trial , 2005 .

[8]  B. Woda,et al.  Facile, comprehensive, high-throughput genotyping of human genital papillomaviruses using spectrally addressable liquid bead microarrays. , 2005, The Journal of molecular diagnostics : JMD.

[9]  C. Wheeler,et al.  A study of the impact of adding HPV types to cervical cancer screening and triage tests. , 2005, Journal of the National Cancer Institute.

[10]  Daron G Ferris,et al.  Efficacy of a bivalent L 1 virus-like particle vaccine in prevention of infection with human papillomavirus types 16 and 18 in young women : a randomised controlled trial , 2005 .

[11]  C. Meijer,et al.  HPV DNA detection and typing in cervical scrapes. , 2005, Methods in molecular medicine.

[12]  Daron G Ferris,et al.  Efficacy of a bivalent L1 virus-like particle vaccine in prevention of infection with human papillomavirus types 16 and 18 in young women: a randomised controlled trial , 2004, The Lancet.

[13]  Claude Fauquet,et al.  Classification of papillomaviruses. , 2004, Virology.

[14]  D. Lowy,et al.  Re: Specific Antibody Levels at the Cervix During the Menstrual Cycle of Women Vaccinated With Human Papillomavirus 16 Virus-Like Particles , 2004 .

[15]  M. Welsh,et al.  Propagation of infectious human papillomavirus type 16 by using an adenovirus and Cre/LoxP mechanism , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[16]  J. Stanford,et al.  Serologic evidence of human papillomavirus 16 and 18 infections and risk of prostate cancer. , 2003, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[17]  F. X. Bosch,et al.  Epidemiologic classification of human papillomavirus types associated with cervical cancer. , 2003, The New England journal of medicine.

[18]  M. Plummer,et al.  Human papillomavirus types in invasive cervical cancer worldwide: a meta-analysis , 2003, British Journal of Cancer.

[19]  D. Lowy,et al.  Specific antibody levels at the cervix during the menstrual cycle of women vaccinated with human papillomavirus 16 virus-like particles. , 2003, Journal of the National Cancer Institute.

[20]  C. Wheeler,et al.  A controlled trial of a human papillomavirus type 16 vaccine. , 2002, The New England journal of medicine.

[21]  M. Pawlita,et al.  HPV antibody detection by ELISA with capsid protein L1 fused to glutathione S-transferase. , 2002, Journal of virological methods.

[22]  I. Frazer,et al.  [Immunogenicity study of HPV 6b virus-like particles]. , 2002, Zhonghua yi xue za zhi.

[23]  Howard D. Strickler,et al.  Enhanced Enzyme-Linked Immunosorbent Assay for Detection of Antibodies to Virus-Like Particles of Human Papillomavirus , 2002, Journal of Clinical Microbiology.

[24]  J. T. Cox,et al.  Effects of age and human papilloma viral load on colposcopy triage: data from the randomized Atypical Squamous Cells of Undetermined Significance/Low-Grade Squamous Intraepithelial Lesion Triage Study (ALTS). , 2002, Journal of the National Cancer Institute.

[25]  P. Coursaget,et al.  Prevalence of Anti-Human Papillomavirus Type 16, 18, 31, and 58 Virus-Like Particles in Women in the General Population and in Prostitutes , 2001, Journal of Clinical Microbiology.

[26]  W. Quint,et al.  Molecular detection and genotyping of human papillomavirus , 2001, Expert review of molecular diagnostics.

[27]  K. Jansen,et al.  Antibody, cytokine and cytotoxic T lymphocyte responses in chimpanzees immunized with human papillomavirus virus-like particles. , 2001, Vaccine.

[28]  J. Cuzick,et al.  HPV testing in primary screening of older women , 1999, British Journal of Cancer.

[29]  C. Peyton,et al.  Genotyping of 27 Human Papillomavirus Types by Using L1 Consensus PCR Products by a Single-Hybridization, Reverse Line Blot Detection Method , 1998, Journal of Clinical Microbiology.

[30]  M. Ozbun,et al.  Synthesis of infectious human papillomavirus type 18 in differentiating epithelium transfected with viral DNA , 1997, Journal of virology.

[31]  H. B. Lim,et al.  Induction of human papillomavirus type 18 late gene expression and genomic amplification in organotypic cultures from transfected DNA templates , 1997, Journal of virology.

[32]  V. Moreno,et al.  Prevalence of Human Papillomavirus in Cervical Cancer: a Worldwide Perspective , 1995 .

[33]  J. Dillner,et al.  Association of serum immunoglobulin G antibodies against human papillomavirus type 16 capsids with anal epidermoid carcinoma. , 1995, Journal of the National Cancer Institute.

[34]  V. Moreno,et al.  Prevalence of human papillomavirus in cervical cancer: a worldwide perspective. International biological study on cervical cancer (IBSCC) Study Group. , 1995, Journal of the National Cancer Institute.

[35]  C. Meyers,et al.  Biosynthesis of human papillomavirus from a continuous cell line upon epithelial differentiation. , 1992, Science.